Skip to content

Preop COVID Testing Patterns

Preoperative COVID Testing as a Predictor of Community Disease Burden

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04838119
Enrollment
375692
Registered
2021-04-08
Start date
2021-04-01
Completion date
2021-08-23
Last updated
2021-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Keywords

Testing, preoperative

Brief summary

This study is an investigation of preoperative asymptomatic COVID screening nationwide. The hypothesis is that because these tests are performed without reference to pretest probability of COVID-19 disease, unlike tests based on symptoms or close contact with infected individuals, these studies may represent a more unbiased sample of the local population prevalence of asymptomatic COVID disease burden.

Detailed description

Study will gather publicly reported, aggregated statistics on positive COVID tests over time and across geographically diverse parts of the United States, summarized weekly, from the onset of the pandemic in Spring 2020 to the present time. Study will also gather contemporaneous data on weekly community COVID cases diagnosed, local positive test percentage, hospital admissions and ICU admissions for COVID-19, and deaths from COVID 19. Similar data will be obtained from a coalition of approximately 20 academic medical centers from around the United States, with Wake Forest School of Medicine, Department of Anesthesiology serving as the coordinating center. No individual patient information will be collected. Aggregated testing data, hospital disease burden, and local disease prevalence are all publicly reported. Data will analyzed as interrupted time series.

Interventions

None listed

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* having preoperative asymptomatic COVID testing * \> or = 18 years of age

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Percentage of asymptomatic preoperative COVID-19 positive testingMarch 2020-February 2021

Secondary

MeasureTime frame
Percentage of hospitalization per geographic areaMarch 2020-February 2021
Percentage of death per geographic areaMarch 2020-February 2021
ICU census per geographic areaMarch 2020-February 2021
Percentage of asymptomatic preoperative COVID-19 positive testing per geographic areaMarch 2020-February 2021

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026